alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          FEB-28-2001
<PERIOD-START>                             MAR-01-2000
<PERIOD-END>                               AUG-31-2000
<CASH>                                           8,203
<SECURITIES>                                         0
<RECEIVABLES>                                   21,975
<ALLOWANCES>                                         0
<INVENTORY>                                    277,869
<CURRENT-ASSETS>                                     0
<PP&E>                                           8,279
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 341,656
<CURRENT-LIABILITIES>                                0
<BONDS>                                         59,792
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         1,500
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                   341,656
<SALES>                                        161,249
<TOTAL-REVENUES>                                     0
<CGS>                                          123,968
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                18,542
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              13,559
<INCOME-PRETAX>                                  4,303
<INCOME-TAX>                                       860
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                  1,390
<CHANGES>                                            0
<NET-INCOME>                                     4,833
<EPS-BASIC>                                        .35
<EPS-DILUTED>                                      .35


</TABLE>
Affirmed and Memorandum Opinion filed September 9, 2014.

In The

Fourteenth Court of Appeals

NO. 14-13-00256-CR

MILTON WHITING, Appellant

V.

THE STATE OF TEXAS, Appellee

On Appeal from the 174th District Court

Harris County, Texas

Trial Court Cause No. 1365102

M E M O R A N D U M O P I N I O N

After a jury trial, appellant was convicted of aggravated sexual assault of a 

child, and sentenced by the trial court to sixty years’ confinement in the 

Institutional Division of the Texas Department of Criminal Justice. 

Appellant is represented on appeal by retained counsel. Appellant’s brief 

was originally due July 1, 2013, but no brief has been filed. This court twice abated 

the appeal and directed the trial court to conduct hearings to determine the reason 
2

for the failure to file a brief pursuant to Texas Rule of Appellate Procedure 38.8(b). 

The trial court held both hearings, and each time appellant confirmed to the court 

that he wished counsel to remain his attorney on appeal. At each hearing, counsel 

advised the court that only minor portions of the brief needed to be completed and 

he would file the brief within a matter of days. The trial court found appellant is 

not indigent, and that he desires to have retained counsel represent him on appeal.

On June 24, 2014, this court ordered counsel to file a brief on or before July 

18, 2014. The court explained that if counsel did not timely file appellant’s brief as 

ordered, the court would consider the appeal without briefs. See Tex. R. App. P. 

38.8(b)(4). Still, no brief was filed.

On the basis of the trial court’s findings, this court has considered the appeal 

without briefs. See Tex. R. App. P. 38.8(b). We find no fundamental error.

Accordingly, the judgment of the trial court is affirmed.

PER CURIAM

Panel consists of Chief Justice Frost and Justices Donovan and Brown.

Do Not Publish — Tex. R. App. P. 47.2(b).
<PAGE>   1
<TABLE>
                                                                      Exhibit 11


                            SUMMIT TECHNOLOGY, INC.

                STATEMENT RE:  COMPUTATION OF PER SHARE EARNINGS

<CAPTION>
                                                   THREE MONTHS                       NINE MONTHS
                                                 ENDED SEPTEMBER 30,              ENDED SEPTEMBER 30,
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)        1995             1994             1995           1994
---------------------------------------------------------------------------------------------------------
<S>                                           <C>              <C>              <C>             <C>
Net income (loss)                             $   273          $(3,191)         $(3,698)        $(11,681)
                                              =======          =======          =======         ========
Primary income (loss) per share:                               
                                                               
Common stock                                   16,834           16,368           16,818           16,355
Stock options                                     259                -                -                -
                                              -------          -------          -------         --------
Weighted average common shares                                 
   outstanding                                 17,093           16,368           16,818           16,355
                                              -------          -------          -------         --------
                                                               
Income (loss) per share                       $   .02          $  (.19)         $  (.22)        $   (.71)
                                              =======          =======          =======         ========
Fully diluted income (loss) per share:                         
                                                               
Common stock                                   16,834           16,368           16,818           16,355
Stock options                                     261                -                -                -
                                              -------          -------          -------         --------
Weighted average common shares                                 
   outstanding                                 17,095           16,368           16,818           16,355
                                              -------          -------          -------         --------
Income (loss) per share                       $   .02          $  (.19)         $  (.22)        $   (.71)
                                              =======          =======          =======         ========
</TABLE>


                                     - 14 -
§ 582.3670 Propylparaben. ( a ) *Product.* Propylparaben (propyl *p*-hydroxybenzoate).
( b ) *Tolerance.* This substance is generally recognized as safe for use at a level not exceeding 0.1 percent in accordance with good manufacturing or feeding practice.
1

Date: November 8, 2011

From: Agency for Toxic Substances and Disease Registry

Subject: Comments on EPA’s Toxicological Review of Ammonia

To: Environmental Protection Agency

ATSDR’s Division of Toxicology and Environmental Me dicine (DTEM) has completed a review of the IRIS toxicological review of ammonia. We appreciate the opportunity to comment. Overall, EPA’s document is very thorough and well written; therefore we have only a few minor comments.

ATSDR has a Toxicological Profile for Ammonia that was published in 2004. ATSDR has two inhalation Minimal Risk Levels (MRLs) for a mmonia: an acute inhalation MRL of 1.7 ppm and a chronic inhalation MRL of 0.1 ppm. While ATSDR has an acute inhalation MRL, EPA has not developed an acute RfC. ATSDR’s chronic MRL is based on the same study (Holness et al. 1989) that EPA us ed to base their proposed chronic RfC of 0.3 mg/m 3 (0.4 ppm). For the chronic MRL, ATSDR used the mea n TWA ammonia concentration of 9.2 ppm from the Holness et al. (1 989) study, adjusted for continuous exposure and divided by an uncertainty factor of 10 for protection of sensitive individuals and a modifying factor of 3 for lack of reproductiv e and developmental studies. EPA’s proposed RfC is based on the high exposure category of 12.5 ppm (8.8 mg/m 3 ) from the Holness et al. (1989) study, adjusted for continuou s exposure and divided by an uncertainty factor of 10 to account for potentially susceptible individuals. Overall, the values use a slightly different NOAEL but the EPA c hronic RfC is similar to the ATSDR chronic MRL for ammonia. Therefore, we have no obj ections to EPA’s conclusions.

Specific Comments :

Page 8, Line 30 – Souba 1987 is cited referring to Figures 3-1 and 3-2. Should this citation be Nelson and Cox (2008) as stated in the footnote for these two figures?

Page 16, Line 35 – Add 40 ppm to list of exposure l evels. See page C-35.

Page 17, Line 7 – Consider adding “However, brief e xposure to 150-200 ppm produced

lacrimation and transient discomfort”, as stated on page C-33. DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Agency for Toxic Substances and Disease Registry



## MemorandumPage 28, Line 24 – Suggest replacing “over a long p eriod of time” with “duration not

specified”.

Page 38, Section 4.3 Reproductive/Developmental Stu dies – Consider adding Minana et

al. 1995 to discussion. Miñana MD, Marcaida G, Gri solia S, et al. 1995. Prenatal exposure of rats to ammonia impairs NMDA receptor f unction and affords delayed protection against ammonia toxicity and glutamate n eurotoxicity. J Neuropathol Exp Neurol 54(5):644-650.

Overall, we consider the questions in the Charge to External Reviewers appropriate.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Energy

###### Federal Energy Regulatory Commission 

          - [Docket No. EC10-44-000] 

Take notice that on February 16, 2010, Crescent Ridge LLC filed a supplement to its February 2, 2010 section 203 application. 

Any person desiring to intervene or to protest this filing must file in accordance with Rules 211 and 214 of the Commission's Rules of Practice and Procedure (18 CFR 385.211, 385.214). Protests will be considered by the Commission in determining the appropriate action to be taken, but will not serve to make protestants parties to the proceeding. Any person wishing to become a party must file a notice of intervention or motion to intervene, as appropriate. Such notices, motions, or protests must be filed on or before the comment date. Anyone filing a motion to intervene or protest must serve a copy of that document on the Applicant and all the parties in this proceeding. 

                    The Commission encourages electronic submission of protests and interventions in lieu of paper using the “eFiling” link at                     *http://www.ferc.gov.*                     Persons unable to file electronically should submit an original and 14 copies of the protest or intervention to the Federal Energy Regulatory Commission, 888 First Street, NE., Washington, DC 20426.                 

                    This filing is accessible on-line at                     *http://www.ferc.gov,*                     using the “eLibrary” link and is available for review in the Commission's Public Reference Room in Washington, DC. There is an “eSubscription” link on the Web site that enables subscribers to receive e-mail notification when a document is added to a subscribed docket(s). For assistance with any FERC Online service, please e-mail                     *FERCOnlineSupport@ferc.gov,*                     or call (866) 208-3676 (toll free). For TTY, call (202) 502-8659.                 

*Comment Date:*                     5 p.m. Eastern Time on February 26, 2010.                 

Kimberly D. Bose, 

Secretary. 

[FR Doc. 2010-4253 Filed 3-1-10; 8:45 am] 

BILLING CODE 6717-01-P
### Miscellaneous geochemical data from waters in the Upper Animas River Watershed, Colorado

By: Raymond H. JohnsonDouglas B. Yager**

                            https://doi.org/10.3133/ofr20131047

#### Links

- More information:  **USGS Index Page**
-                                                                                                                             Document:                                                                                                                                                                                                                                                  **Report** 
- Companion File:  **Companion Files**
- Download citation as:  RIS                         |                         Dublin                            Core

#### Abstract

#### Study Area

Part or all of this report is presented in Portable Document Format                        (PDF). For best results viewing and printing PDF documents, it is recommended that you download                        the documents to your computer and open them with Adobe Reader. PDF documents opened from your                        browser may not display or print as intended. Download the latest version of Adobe Reader, free of charge. More information                        about viewing, downloading, and printing report files can be found at the common download problems FAQ.
#### § 610.16 Total solids in serums.

Except as otherwise provided by regulation, no liquid serum or antitoxin shall contain more than 20 percent total solids.
IN THE SUPREME COURT OF PENNSYLVANIA

MIDDLE DISTRICT

COMMONWEALTH OF PENNSYLVANIA,

Respondent

v.

DANA GANJEH,

Petitioner

:

:

:

:

:

:

:

:

:

:

:

No. 468 MAL 2023

Petition for Allowance of Appeal 

from the Order of the Superior Court

ORDER

PER CURIAM

AND NOW, this 14th day of February, 2024, the Petition for Allowance of Appeal

is DENIED.
T hi s di s pos i t i on i s notappr opr i a t e f orpubl i c a t i on and i s notpr e c e de nt * e xc e pta s pr ovi de d by9th C i r . R . 36- 3.

T he pa ne l una ni m ous l yc onc l ude s thi s c a s e i s s ui t abl e f orde c i s i on ** w ith o u t o r a l a r g u m e n t. See F ed. R . A pp . P . 34 (a )( 2). E N / R es ear ch NOT F OR P UB L I CAT I ON

UN I TE D STATE S C OU RT OF APPE ALS FOR T HE NI NTH CI RC UI T V IR G IN IA L E G A S P I, P la in tif

f - A p p e lla n t, v. S T . J OS E P H’ S ME DI C AL C E NT E R OF S T O C K T O N ; e t a l., D efen d an t s - A p p el l ees. N o. 08- 17163 D. C . No . 2 : 0 7 - c v - 0 0 2 9 1 - F C DGG H ME MOR AN DU M *

A pp ea l fr om the U ni t ed S t at es D i stri ctC ou rt f o rth e E a s te rn D is tr ic t o f C a lif o rn ia F r a nk C . D a m r e l l , J r . , D i s tr i c tJudge , P r e s i di ng S ubm i tt e d M a r c h 16, 2010 ** B efo re: S C H R O E D E R , P R E G E R S O N , an dR A W L IN S O N , C i rcu i tJu d g es. V i r gi ni aL e ga s pi appe a l s f r om the di s tr i c tc ourt ’ s or de rdi s m i s s i ng he rL abor M a na ge m e ntR e l a t i ons A c ta c t i on f orf a i l ur e t o pr os e c ut e . W e ha ve j ur i s di c t i on



# FI LED APR01 2 010 M OLLY C. DW Y ER, CLERK U . S. C O U R T OF APPE ALSE N / Res ea r ch 08- 17163 2 u n d e r2 8 U .S .C . § 1 2 9 1 . W e r e v ie w f o ra n ab u s e o f

d is c r e tio n , G haz al iv . Mor an, 4 6 F. 3 d5 2 , 5 3 ( 9 th Ci r . 1 9 9 5 ) ( p e rc u r i a m) , a n dw e a f f i rm. T he di s tr i c tc ourtdi d notabus e i t s di s c r e t i on bydi s m i s s i ng the a c t i on w he r e L e ga s pi ’ s c onduc tpr e j udi c e d de f

e nda nt s ’ abi l i tyt o de f

e nd the a c t i on a nd the c ourtha d a l r e a dyw a rne d L e ga s pi s e ve r a l t i m e s tha tf a i l ur e t o c om pl yw i th the c o u rt’s o r d e r s c o u ldr e s u lt in d is m is s a l o f h e ra c tio n . See i d. a t53- 54 ( out l i ni ng fa ct ors t o con si der before di sm i ss i ng an ac t i on for f ai l ure t o fol l ow a di stri ct court ’ s l ocal rul es ). S im il ar ly, th e d istrict co u rt d idn o t ab u se it s d iscr etio n b y d en yin g L eg as p i’ s m ot i on for l eave t o fi l e an u nt i m el y opp osi t i on because herfa i l ure t o p rose cut e w as n e ith e rn e g lig e n t n o re x c u s ab le . Se e B r i ones v . R i v i e r a H ote l & Cas i no , 116 F . 3d 3 7 9 , 3 8 1 -8 2 (9 th C i r. 1 9 9 7 ) (p er cu ri am ) (o b serv i n g th atas a g en eral ru l e “ p ro se l i t i gant s are no texcuse d from fol l ow i ng courtrul es ”) . L egas pi ’ s r em ai ni ng cont ent i on s are un pers uasi ve. AF F I RME D.
#### § 520.2325 Sulfaquinoxaline oral dosage forms.
EXHIBIT 32.1
  
  CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO
 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
 
 This certification is provided pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and accompanies the Quarterly Report on Form 10-Q (the “Form 10-Q”) for the quarter ended March 31, 2010 of Crimson Exploration Inc. (the “Issuer”).  The undersigned hereby certifies that the Form 10-Q fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)) and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Issuer.
 
 Date:
May 11, 2010/s/ Allan D. KeelName:
Allan D. KeelTitle:
President and Chief Executive Officer
 
 
 A signed original of this written statement required by Section 906 has been provided to the Issuer and will be furnished to the Securities and Exchange Commission, or its staff, upon request.
EPA SANITIZED Page 1 of 5
Standard Review Engineering Report CBI: No 

Date: 5 September 2006 

PMN: P-06-702 

Submitter: 

Production Volume: kg/yr 

Use: 

End Use: 

MSDS: 

Equipment in PMN: 

Physical Properties: 

 Physical Form: Liquid 

 Vapor Pressure: < 0.001 torr @ 25 C 

 Solubility in Water: 0.032 gm/L

EPA SANITIZED Page 2 of 5
Standard Review Engineering Report CBI: No 

Date: 5 September 2006 

PMN: P-06-702 

Submitter: 

 No. of Sites: 

 Batch Size: 

 Days/Yr: 

Process Description: 

Environmental Release Estimate Summary: 

Source Media of Release kg/da days/yr kg/yr

Occupation Exposure Estimate Summary: 

Activity Route No. of Workers Exposure

EPA SANITIZED Page 3 of 5
Standard Review Engineering Report CBI: No 

Date: 5 September 2006 

PMN: P-06-702 

Submitter: 

 No. of Sites: 

 Days per Year: 

Process Description: 

Environmental Release Estimate Summary: 

Source Media of Release kg/site/da days/yr kg/yr

Occupational Exposure Estimate Summary: 

Activity Route of Exp. No. of Workers Exposure

EPA SANITIZED Page 4 of 5
Standard Review Engineering Report CBI: No 

Date: 5 September 2006 

PMN: P-06-702 

Submitter: 

 No. of Sites: 

 Days/year: 

Environmental Release Estimate Summary: 

Source Media of Release kg/da days/yr kg/yr (all sites)

Occupational Exposure Estimate Summary: 

Activity Route of Exp. No. of Workers Exposure

EPA SANITIZED Page 5 of 5
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
Consolidated Balance Statement and Consolidated Statement of Operations of
Signature X Ltd. Limited Partnership as of and for the three month period ended
September 30, 1995, and is qualified in its entirety by reference to such
financial statements.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-END>                               SEP-30-1995
<CASH>                                         536,986
<SECURITIES>                                         0
<RECEIVABLES>                                   62,226
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               675,271
<PP&E>                                      10,781,629
<DEPRECIATION>                               2,999,864
<TOTAL-ASSETS>                               8,660,166
<CURRENT-LIABILITIES>                          348,856
<BONDS>                                      7,882,256
<COMMON>                                             0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                     429,054
<TOTAL-LIABILITY-AND-EQUITY>                 8,660,166
<SALES>                                              0
<TOTAL-REVENUES>                             1,008,431
<CGS>                                                0
<TOTAL-COSTS>                                  660,701
<OTHER-EXPENSES>                                73,818
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             138,996
<INCOME-PRETAX>                                134,916
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            134,916
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   134,916
<EPS-PRIMARY>                                   370.65
<EPS-DILUTED>                                   370.65
        

</TABLE>
§ 516.121 Meetings. ( a ) A requestor or potential requestor is entitled to one or more meetings to discuss the requirements for indexing a new animal drug.
( b ) Requests for such meetings should be in writing, be addressed to the Director, OMUMS, specify the participants attending on behalf of the requestor or potential requestor, and contain a proposed agenda for the meeting.
( c ) Within 30 days of receiving a request for a meeting, FDA will attempt to schedule the meeting at a time agreeable to both FDA and the person making the request.